Ezio Bonvini

Senior Vice President, Research & Chief Scientific Officer at MacroGenics, Inc.

Ezio Bonvini

Ezio Bonvini

Senior Vice President, Research & Chief Scientific Officer at MacroGenics, Inc.

Overview
RelSci Relationships

209

Birthday

1954

Age

64

Relationships
RelSci Relationships are individuals Ezio Bonvini likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at MacroGenics, Inc.

Relationship likelihood: Strong

Chief Biotechnology Officer at Janssen Research & Development LLC

Relationship likelihood: Strong

Senior Vice President, Chief Financial Officer & Secretary at MacroGenics, Inc.

Relationship likelihood: Strong

Treasurer, CAO, Vice President & Controller at MacroGenics, Inc.

Relationship likelihood: Strong

Senior Vice President, Clinical Development & Chief Medical Officer at MacroGenics, Inc.

Relationship likelihood: Strong

Former Senior Vice President-Product Development & Regulatory Affairs at MacroGenics, Inc.

Relationship likelihood: Strong

General Counsel at MacroGenics, Inc.

Relationship likelihood: Strong

Senior Vice President, Business Development & Portfolio Management & Chief Business Officer at MacroGenics, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Novartis Corporation

Relationship likelihood: Strong

Managing Director at Five Corners Capital, Inc.

Relationship likelihood: Strong

Paths to Ezio Bonvini
Potential Connections via
Relationship Science
You
Ezio Bonvini
Senior Vice President, Research & Chief Scientific Officer at MacroGenics, Inc.
Education
MD Clinical Hematology

The University of Genoa is one of the most valuable cultural and scientific heritage of the Mediterranean and the Italian north-western area. It is deeply interconnected with the city of Genoa and its economic framework. The University is located throughout the region, with campuses also in Savona, Imperia and La Spezia.

Career History
Senior Vice President, Research & Chief Scientific Officer
2003 - Current

MacroGenics is a leader in the discovery and development of innovative medicinces that utilize our next generation antibody-based technologies. Our team of 150+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer and other serious, complex diseases. Our products and platforms have attracted multiple partnerships with leading pharmaceutical companies around the globe. Our innovative product candidates leverage our fully-integrated capabilities around the discovery, development, and production of antibodies and incorporate three proprietary technology platforms: Our Dual-Affinity Re-Targeting (DART™) platform enables us to design candidate therapeutics that target multiple disease-causing cells or redundant disease-associated pathways with a single molecule; Our Fc Optimization platform enhances the natural immune system's ability to mediate killing of cancer cells; and Our Cancer Stem Cell platform provides new approaches to target cancers unresponsive to current therapy.

Visiting Fellow
1982 - 1984

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Director-Deputy Division
Prior

Center for Biologics Evaluation & Research engages in the regulation of biological and related products. Its scope includes blood, vaccines, allergenics, tissues, and cellular and gene therapies. The company is headquartered in Silver Spring, MD.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$50 - $99
2013

The American Association of Immunologists is an association of professionally trained scientists from all over the world dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and information among investigators, and addressing the potential integration of immunologic principles into clinical practice. The American Association of Immunologists serves its members by providing a center for the dissemination of information relevant to the field and its practices, such as educational and professional opportunities, scientific meetings, membership-derived issues and opinions, and important social and political issues. AAI owns and publishes The Journal of Immunology—the largest and most highly cited journal in the field.

$50 - $99
2012

The American Association of Immunologists is an association of professionally trained scientists from all over the world dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and information among investigators, and addressing the potential integration of immunologic principles into clinical practice. The American Association of Immunologists serves its members by providing a center for the dissemination of information relevant to the field and its practices, such as educational and professional opportunities, scientific meetings, membership-derived issues and opinions, and important social and political issues. AAI owns and publishes The Journal of Immunology—the largest and most highly cited journal in the field.

$1 - $99
2008

The American Association of Immunologists is an association of professionally trained scientists from all over the world dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and information among investigators, and addressing the potential integration of immunologic principles into clinical practice. The American Association of Immunologists serves its members by providing a center for the dissemination of information relevant to the field and its practices, such as educational and professional opportunities, scientific meetings, membership-derived issues and opinions, and important social and political issues. AAI owns and publishes The Journal of Immunology—the largest and most highly cited journal in the field.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ezio Bonvini. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ezio Bonvini's profile does not indicate a business or promotional relationship of any kind between RelSci and Ezio Bonvini.